Skip to search formSkip to main contentSkip to account menu

N(4)-oleylcytosine arabinoside

Known as: NOAC 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Cytarabine
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2018
Highly Cited
2018
Efficacy and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Asians With Nonvalvular Atrial Fibrillation
Background Whether non–vitamin K antagonist oral anticoagulants (NOACs) are superior to warfarin among Asians with nonvalvular… 
Highly Cited
2017
Highly Cited
2017
Increased use of oral anticoagulants in patients with atrial fibrillation: temporal trends from 2005 to 2015 in Denmark
Aim The aim of this study is to examine temporal trends in the use oral anticoagulants (OAC) as stroke prophylaxis in patients… 
Review
2017
Review
2017
Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses.
Review
2016
Review
2016
Nonvitamin K Anticoagulant Agents in Patients With Advanced Chronic Kidney Disease or on Dialysis With AF.
Review
2015
Review
2015
Non-vitamin K antagonist oral anticoagulants: considerations on once- vs. twice-daily regimens and their potential impact on medication adherence.
Suboptimal medication adherence is a widespread problem in ambulatory care of chronic diseases, with deviations in either… 
Highly Cited
2015
Highly Cited
2015
Trends in Prescribing Oral Anticoagulants in Canada, 2008-2014.
Review
2015
Review
2015
Non‐vitamin K antagonist oral anticoagulants (NOACs) in patients with concomitant atrial fibrillation and heart failure: a systemic review and meta‐analysis of randomized trials
No pooled analysis has been undertaken to assess the efficacy and safety of the non‐vitamin K antagonist oral anticoagulants… 
Review
2014
Review
2014
New Oral Anticoagulants in Elderly Adults: Evidence from a Meta‐Analysis of Randomized Trials
To evaluate the efficacy and safety of new oral anticoagulants (NOACs) in elderly adults. 
Highly Cited
2014
Highly Cited
2014
Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel
Note: The editorial process for this paper was fully handled by Prof Christian Weber, Editor in Chief. 
Review
2014
Review
2014
Inappropriate use of oral anticoagulants for patients with atrial fibrillation.
BACKGROUND Atrial fibrillation (AF) is a common arrhythmic disorder among the elderly, and increases the risk of stroke. Oral… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)